UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 3.920

Sortiert nach

Analgesic Efficacy and Safety of Oxycodone in Combination With Naloxone as Prolonged Release Tablets in Patients With Moderate to Severe Chronic Pain

The journal of pain, 2008-12, Vol.9 (12), p.1144-1154

2008

Volltextzugriff (PDF)

Effect of prenatal and early post-natal oxycodone exposure on the reinforcing and antinociceptive effects of oxycodone in adult C57BL/6 J mice

Psychopharmacology, 2024-02, Vol.241 (2), p.359-377

2024

Volltextzugriff (PDF)

Preclinical Efficacy and Characterization of Candidate Vaccines for Treatment of Opioid Use Disorders Using Clinically Viable Carrier Proteins

Molecular pharmaceutics, 2018-11, Vol.15 (11), p.4947-4962

2018

Volltextzugriff (PDF)

Simultaneous quantification and confirmation of oxycodone and its metabolites in equine urine using ultra-high performance liquid chromatography-tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2024-05, Vol.1238, p.124125-124125, Article 124125

2024

Volltextzugriff (PDF)

Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin

JAMA psychiatry (Chicago, Ill.), 2015-05, Vol.72 (5), p.424

2015

Volltextzugriff (PDF)

Oxycodone for neuropathic pain in adults

Cochrane database of systematic reviews, 2016-07, Vol.7 (7), p.CD010692

2016

Volltextzugriff (PDF)

Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety

British journal of pharmacology, 2010-06, Vol.160 (4), p.919-930

2010

Volltextzugriff (PDF)

Rates of opioid dispensing and overdose after introduction of abuse-deterrent extended-release oxycodone and withdrawal of propoxyphene

JAMA internal medicine, 2015-06, Vol.175 (6), p.978

2015

Volltextzugriff (PDF)

Treatment of Diabetic Neuropathy and Neuropathic Pain: How far have we come?

Diabetes care, 2008-02, Vol.31, p.S255-S261

Ziegler, Dan

2008

Volltextzugriff (PDF)

Chemoenzymatic Total Synthesis of (+)-10-Keto-Oxycodone from Phenethyl Acetate

Molecules (Basel, Switzerland), 2019-09, Vol.24 (19), p.3477

2019

Volltextzugriff (PDF)

Opioids for cancer pain - an overview of Cochrane reviews

Cochrane database of systematic reviews, 2017-07, Vol.7 (7), p.CD012592

2017

Volltextzugriff (PDF)

The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone

British journal of pharmacology, 2010-06, Vol.160 (4), p.907-918

2010

Volltextzugriff (PDF)

Central nervous system penetration of oxycodone after intravenous and epidural administration

British journal of anaesthesia : BJA, 2014-01, Vol.112 (1), p.133-140

2014

Volltextzugriff (PDF)

Recent trends in heroin and pharmaceutical opioid‐related harms in Victoria, Australia up to 2018

Addiction (Abingdon, England), 2020-02, Vol.115 (2), p.261-269

2020

Volltextzugriff (PDF)

An Update on the Pharmacological Management of Post-Herpetic Neuralgia and Painful Diabetic Neuropathy

CNS drugs, 2008-01, Vol.22 (5), p.417-442

2008

Volltextzugriff (PDF)

Oxycodone‐induced tolerance to respiratory depression: reversal by ethanol, pregabalin and protein kinase C inhibition

British journal of pharmacology, 2018-06, Vol.175 (12), p.2492-2503

2018

Volltextzugriff (PDF)

PharmGKB summary: oxycodone pathway, pharmacokinetics

Pharmacogenetics and genomics, 2018-10, Vol.28 (10), p.230-237

2018

Volltextzugriff (PDF)

A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates

Science translational medicine, 2018-08, Vol.10 (456)

2018

Volltextzugriff (PDF)

Trends in Opioid Analgesic Abuse and Mortality in the United States

The New England journal of medicine, 2015-01, Vol.372 (3), p.241-248

2015

Volltextzugriff (PDF)

An alternating polarity switching assay for quantification of oxycodone and topiramate: An application of LC-MS/MS method in support to PK/PD study in rodents

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2019-06, Vol.1118-1119, p.93-100

2019

Volltextzugriff (PDF)

Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain

Current medical research and opinion, 2008-12, Vol.24 (12), p.3503-3512

2008

Volltextzugriff (PDF)

The effects of (2R,6R)-hydroxynorketamine on oxycodone withdrawal and reinstatement

Drug and alcohol dependence, 2023-12, Vol.253, p.110987-110987, Article 110987

2023

Volltextzugriff (PDF)

Cannabinoid–Opioid Interaction in Chronic Pain

Clinical pharmacology and therapeutics, 2011-12, Vol.90 (6), p.844-851

2011

Volltextzugriff (PDF)

Prescription Opioids in Adolescence and Future Opioid Misuse

Pediatrics (Evanston), 2015-11, Vol.136 (5), p.e1169

2015

Volltextzugriff (PDF)

Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study

European journal of clinical pharmacology, 2012-01, Vol.68 (1), p.55-64

2012

Volltextzugriff (PDF)

1 – 25 von 3.920

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.446)
Mit Volltextzugriff
(3.008)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.933)
Life Sciences & Biomedicine
(2.834)
Humans
(2.567)
Oxycodone
(2.259)
Male
(1.557)
Female
(1.470)
Adult
(1.026)
Oxycodone - Administration & Dosage
(983)
Narcotics
(974)
Middle Aged
(950)
Oxycodone - Therapeutic Use
(947)
Analgesics, Opioid - Therapeutic Use
(866)
Opioids
(840)
Analgesics, Opioid - Administration & Dosage
(812)
Pharmacology & Pharmacy
(769)
Pain
(735)
Analgesics
(713)
Oxycodone - Adverse Effects
(699)
Aged
(657)
Analgesics, Opioid - Adverse Effects
(640)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Analgesic Efficacy and Safety of Oxycodone in Combination With Naloxone as Prolonged Release Tablets in Patients With Moderate to Severe Chronic Pain

Effect of prenatal and early post-natal oxycodone exposure on the reinforcing and antinociceptive effects of oxycodone in adult C57BL/6 J mice

Preclinical Efficacy and Characterization of Candidate Vaccines for Treatment of Opioid Use Disorders Using Clinically Viable Carrier Proteins

Simultaneous quantification and confirmation of oxycodone and its metabolites in equine urine using ultra-high performance liquid chromatography-tandem mass spectrometry

Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin

Oxycodone for neuropathic pain in adults

Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety

Rates of opioid dispensing and overdose after introduction of abuse-deterrent extended-release oxycodone and withdrawal of propoxyphene

Treatment of Diabetic Neuropathy and Neuropathic Pain: How far have we come?

Chemoenzymatic Total Synthesis of (+)-10-Keto-Oxycodone from Phenethyl Acetate

Opioids for cancer pain - an overview of Cochrane reviews

The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone

Central nervous system penetration of oxycodone after intravenous and epidural administration

Recent trends in heroin and pharmaceutical opioid‐related harms in Victoria, Australia up to 2018

An Update on the Pharmacological Management of Post-Herpetic Neuralgia and Painful Diabetic Neuropathy

Oxycodone‐induced tolerance to respiratory depression: reversal by ethanol, pregabalin and protein kinase C inhibition

PharmGKB summary: oxycodone pathway, pharmacokinetics

A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates

Trends in Opioid Analgesic Abuse and Mortality in the United States

An alternating polarity switching assay for quantification of oxycodone and topiramate: An application of LC-MS/MS method in support to PK/PD study in rodents

Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain

The effects of (2R,6R)-hydroxynorketamine on oxycodone withdrawal and reinstatement

Cannabinoid–Opioid Interaction in Chronic Pain

Prescription Opioids in Adolescence and Future Opioid Misuse

Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study

Suchergebnisse filtern